02/28
Headlines

Finance

Most Volatile Biotech Stocks: IGI Laboratories (NYSEMKT:IG), 22nd Century Group (NYSEMKT:XXII), PharmAthene (NYSEMKT:PIP), Pacific Biosciences of California (NASDAQ:PACB)

Jason Knox02 mins

IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey-based generic topical pharmaceutical company, today announced that it has appointed Damian Finio to its Board of Directors. Mr. Finio will serve as the new Chairman of the Company’s Audit Committee. IGI Laboratories, Inc. (NYSEMKT:IG) stock performance was -10.79% in last session and finished the day at $4.88. Traded…

Read More

Biotech Touched New Lows: Celladon (NASDAQ:CLDN), MediciNova (NASDAQ:MNOV), Mediwound (NASDAQ:MDWD), Celsion Corporation (NASDAQ:CLSN)

Jason Knox02 mins

Celladon Corporation (NASDAQ:CLDN) was a big mover last session, as its shares rose nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the healthcare company since March 24, as the stock is down nearly 25%. Celladon…

Read More

Biotech Bearish Stocks: Conatus Pharmaceuticals Inc (NASDAQ:CNAT), Kindred Biosciences (NASDAQ:KIN), BIND Therapeutics (NASDAQ:BIND), Aratana Therapeutics (NASDAQ:PETX)

Kristen Barton02 mins

Conatus Pharmaceuticals Inc (NASDAQ:CNAT) was the recipient of a large growth in short interest in January. As of March 14th, there was short interest totalling 985,400 shares, a growth of 82.6% from the February 28th total of 539,790 shares, Analyst Ratings News reports. Conatus Pharmaceuticals Inc (NASDAQ:CNAT) stock performance was -6.33% in last session and…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Bullish Stocks: Regulus Therapeutics Inc (NASDAQ:RGLS), Insys Therapeutics (NASDAQ:INSY), Repligen Corporation (NASDAQ:RGEN), Sarepta Therapeutics (NASDAQ:SRPT)

Kevin Long02 mins

Shares of Regulus Therapeutics Inc (NASDAQ:RGLS) were the target of a significant decrease in short interest in January. As of March 14th, there was short interest totaling 1,460,571 shares, a decrease of 20.3% from the February 28th total of 1,832,140 shares, Analyst Ratings Newsreports. Regulus Therapeutics Inc (NASDAQ:RGLS) stock performance was 5.09% in last session…

Read More
Gilead Sciences GILD NASDAQ:GILD

Active runners at NASDAQ runners: Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Zynga Inc (NASDAQ:ZNGA), Cisco Systems, Inc. (NASDAQ:CSCO)

Kristen Barton02 mins

Facebook Inc (NASDAQ:FB) was among the hardest hit during Friday’s tech-sector sell-off, closing at a two-month low. So far today, the social networking stock has explored both sides of breakeven, but was last seen fractionally higher at $56.77. Facebook Inc (NASDAQ:FB) stock performance was 0.35% in last session and finished the day at $56.95. Traded…

Read More
Gilead Sciences GILD NASDAQ:GILD

Investor’s Alert: BlackBerry Ltd (NASDAQ:BBRY), Tesla Motors Inc (NASDAQ:TSLA), Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK)

Jayne Crisman02 mins

BlackBerry Ltd (NASDAQ:BBRY) announced that it will not be renewing T-Mobile’s license to sell BlackBerry products once the existing contract expires on April 25, 2014. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -2.69% in last session and finished the day at $8.00. Traded volume was 12.90million shares in the last session and the average volume of…

Read More